These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 9731006)
1. Effects of theophylline on tolerance to the bronchoprotective actions of salmeterol in asthmatics in vivo. Cheung D; Wever AM; de GOEIJ JA; de GRAAFF CS; Steen H; Sterk PJ Am J Respir Crit Care Med; 1998 Sep; 158(3):792-6. PubMed ID: 9731006 [TBL] [Abstract][Full Text] [Related]
2. Effect of regular salmeterol treatment on albuterol-induced bronchoprotection in mild asthma. Yates DH; Worsdell M; Barnes PJ Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):988-91. PubMed ID: 9310023 [TBL] [Abstract][Full Text] [Related]
3. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. Cheung D; Timmers MC; Zwinderman AH; Bel EH; Dijkman JH; Sterk PJ N Engl J Med; 1992 Oct; 327(17):1198-203. PubMed ID: 1357550 [TBL] [Abstract][Full Text] [Related]
4. An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist. Yates DH; Kharitonov SA; Barnes PJ Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1603-7. PubMed ID: 8970342 [TBL] [Abstract][Full Text] [Related]
5. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol. Kalra S; Swystun VA; Bhagat R; Cockcroft DW Chest; 1996 Apr; 109(4):953-6. PubMed ID: 8635376 [TBL] [Abstract][Full Text] [Related]
6. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists. van der Woude HJ; Winter TH; Aalbers R Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351 [TBL] [Abstract][Full Text] [Related]
7. Comparison of salmeterol and albuterol-induced bronchoprotection against adenosine monophosphate and histamine in mild asthma. Taylor DA; Jensen MW; Aikman SL; Harris JG; Barnes PJ; O'Connor BJ Am J Respir Crit Care Med; 1997 Dec; 156(6):1731-7. PubMed ID: 9412548 [TBL] [Abstract][Full Text] [Related]
8. Tolerance to the bronchoprotective effect of salmeterol 12 hours after starting twice daily treatment. Drotar DE; Davis EE; Cockcroft DW Ann Allergy Asthma Immunol; 1998 Jan; 80(1):31-4. PubMed ID: 9475563 [TBL] [Abstract][Full Text] [Related]
9. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Woolcock A; Lundback B; Ringdal N; Jacques LA Am J Respir Crit Care Med; 1996 May; 153(5):1481-8. PubMed ID: 8630590 [TBL] [Abstract][Full Text] [Related]
10. Salmeterol prevents aspirin-induced attacks of asthma and interferes with eicosanoid metabolism. Szczeklik A; Dworski R; Mastalerz L; Prokop A; Sheller JR; Nizankowska E; Cmiel A; Oates JA Am J Respir Crit Care Med; 1998 Oct; 158(4):1168-72. PubMed ID: 9769277 [TBL] [Abstract][Full Text] [Related]
11. Salmeterol versus theophylline in the treatment of asthma. Pollard SJ; Spector SL; Yancey SW; Cox FM; Emmett A Ann Allergy Asthma Immunol; 1997 May; 78(5):457-64. PubMed ID: 9164358 [TBL] [Abstract][Full Text] [Related]
12. Long-term circadian effects of salmeterol in asthmatic children treated with inhaled corticosteroids. Meijer GG; Postma DS; Mulder PG; van Aalderen WM Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):1887-92. PubMed ID: 8520751 [TBL] [Abstract][Full Text] [Related]
13. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma. Aziz I; Hall IP; McFarlane LC; Lipworth BJ J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449 [TBL] [Abstract][Full Text] [Related]
14. A high dose of albuterol does not overcome bronchoprotective subsensitivity in asthmatic subjects receiving regular salmeterol or formoterol. Lipworth BJ; Aziz I J Allergy Clin Immunol; 1999 Jan; 103(1 Pt 1):88-92. PubMed ID: 9893190 [TBL] [Abstract][Full Text] [Related]
15. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness. Rosenthal RR; Busse WW; Kemp JP; Baker JW; Kalberg C; Emmett A; Rickard KA Chest; 1999 Sep; 116(3):595-602. PubMed ID: 10492259 [TBL] [Abstract][Full Text] [Related]
16. Tolerance to the protective effects of salmeterol on methacholine-induced bronchoconstriction: influence of inhaled corticosteroids. Boulet LP; Cartier A; Milot J; Côté J; Malo JL; Laviolette M Eur Respir J; 1998 May; 11(5):1091-7. PubMed ID: 9648961 [TBL] [Abstract][Full Text] [Related]
17. Rapid onset of tolerance to the bronchoprotective effect of salmeterol. Bhagat R; Kalra S; Swystun VA; Cockcroft DW Chest; 1995 Nov; 108(5):1235-9. PubMed ID: 7587422 [TBL] [Abstract][Full Text] [Related]
18. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma. Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216 [TBL] [Abstract][Full Text] [Related]
19. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide. de Jong JW; van der Mark TW; Koëter GH; Postma DS Am J Respir Crit Care Med; 1996 Jan; 153(1):70-5. PubMed ID: 8542165 [TBL] [Abstract][Full Text] [Related]
20. Salmeterol vs theophylline: sleep and efficacy outcomes in patients with nocturnal asthma. Wiegand L; Mende CN; Zaidel G; Zwillich CW; Petrocella VJ; Yancey SW; Rickard KA Chest; 1999 Jun; 115(6):1525-32. PubMed ID: 10378544 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]